Vitura Health Limited logo

Vitura Health Limited (VIT)

Market Closed
ASX ASX
26.51M Market Cap
5.25 P/E Ratio
0.01% Div Yield
122,048 Volume
0 Eps
Want to track VIT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VIT pays dividends to its shareholders, with the most recent payment made on Sep 30, 2025. The next estimated payment will be in In 1 month on Sep 30, 2026 for a total of A$0.002.
The last earnings report, released on Feb 23, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on ASX (AUD).

Vitura Health Limited (VIT) FAQ

On which exchange is it traded?

Vitura Health Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is VIT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.01%.

What is its market cap?

As of today, the market cap is 26.51M.

Has Vitura Health Limited ever had a stock split?

No, there has never been a stock split.

Vitura Health Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Shane Francis Tanner A.A.I.M., A.C.I.S., AGIA, FCPA CEO
ASX Exchange
AU0000266801 ISIN
AU Country
- Employees
5 Sep 2025 Last Dividend
- Last Split
- IPO Date

Overview

Vitura Health Limited is an Australian-based company specializing in the sale and distribution of medicinal cannabis products across Australia and Asia. Formerly known as Cronos Australia Limited, the company underwent a name change to Vitura Health Limited in February 2023, signifying a broadened focus in its healthcare offerings. Incorporated in 2018, Vitura Health is headquartered in South Yarra, Australia, positioning itself at the forefront of medicinal cannabis and alternative healthcare solutions within the region. Its operations encompass an online platform, CanView, dedicated to the prescribing, dispensing, and management of medicinal cannabis medications, alongside running CDA Clinics and Cannadoc, which offer consultations and prescription services for medicinal cannabis. Furthermore, Vitura Health is expanding its product line to include psychedelics and plant-based medications, catering to a diverse range of healthcare needs.

Products and Services

  • CanView: An innovative online platform that streamlines the process of prescribing, dispensing, and managing medicinal cannabis medications. CanView serves as a comprehensive solution for healthcare professionals, enabling them to access a range of cannabis-based products for their patients efficiently.
  • CDA Clinics: Specialized clinics providing medicinal cannabis consultations and prescription services. These facilities offer personalized care and expert guidance for patients seeking therapeutic cannabis solutions, ensuring a supportive pathway from consultation to prescription.
  • Cannadoc: Offers telehealth consultations for medicinal cannabis, facilitating access for patients who are unable to attend in-person appointments. Through Cannadoc, patients can receive professional medical advice and prescriptions for cannabis-based treatments conveniently from home.
  • Cortexa: Dedicated to the exploration and distribution of psychedelics for therapeutic use. This brand represents Vitura Health’s venture into the emerging field of psychedelic medicine, offering new treatment options for mental health conditions.
  • Adaya: Focuses on providing plant-based medications, including medium chain triglyceride (MCT) oil and whole flower products. Adaya represents the company’s commitment to offering natural, alternative healthcare solutions alongside its medicinal cannabis products.

Contact Information

Address: Suite 8, Level 3, South Yarra, VIC, Australia, 3141
Phone: 59 6 2907 1594